sj-docx-1-msj-10.1177_13524585231225711 – Supplemental material for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis

Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis by Christopher GS Gilmartin, Natasha Hoyle, Afagh Garjani, Terri Dixon, Helena Jos, David Paling, Wallace Brownlee, Christopher Tench and Nikos Evangelou in Multiple Sclerosis Journal</p

sj-docx-2-msj-10.1177_13524585231225711 – Supplemental material for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis

Supplemental material, sj-docx-2-msj-10.1177_13524585231225711 for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis by Christopher GS Gilmartin, Natasha Hoyle, Afagh Garjani, Terri Dixon, Helena Jos, David Paling, Wallace Brownlee, Christopher Tench and Nikos Evangelou in Multiple Sclerosis Journal</p

sj-docx-3-msj-10.1177_13524585231225711 – Supplemental material for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis

Supplemental material, sj-docx-3-msj-10.1177_13524585231225711 for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis by Christopher GS Gilmartin, Natasha Hoyle, Afagh Garjani, Terri Dixon, Helena Jos, David Paling, Wallace Brownlee, Christopher Tench and Nikos Evangelou in Multiple Sclerosis Journal</p

sj-docx-1-mso-10.1177_20552173231203816 - Supplemental material for Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis

Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis by John Kramer, Ralf Linker, David Paling, Adam Czaplinski, Olaf Hoffmann, V Wee Yong, Noreen Barker, Amy Perrin Ross, Elisabeth Lucassen, Mohammad Gufran, Xixi Hu, Ronald Zielman, Gustavo Seifer and Patrick Vermersch in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p